National Diabetes Services Scheme (NDSS) Products

Closed 2 Jul 2023

Opened 8 Jun 2023


The National Diabetes Services Scheme (NDSS) provides subsidised access to a range of products for the self-management of diabetes.  To ensure the products supplied under the NDSS continue to meet the needs of people registered with the scheme – and represent value-for-money for the Australian Government – the Department of Health and Aged Care is planning a tender process to refresh the NDSS Product Schedule.

The tender would allow new and existing product suppliers to seek subsidisation of their products through the NDSS.  While the categories of products (e.g., test strips, syringes) subsidised under the NDSS will not change, this is an opportunity to refresh the range of specific brands and types of products within each category.

The tender process will not change the eligibility criteria for products and will not consider categories of products that are not already subsidised under the program.

The tender process is expected to include blood glucose test strips (BGTS), syringes, urine test strips and continuous glucose monitoring (CGM) products.

To assist in this process we are seeking feedback on the features and functionality that are most valued in these products and what you would like to see more of (or less of) in the product schedule.

Why your views matter

We are interested in your views on diabetes products to assist us in considering potential changes to the NDSS product schedule.  Please complete the short survey which will take approximately 5-10 minutes.

The survey focuses on collecting feedback from people with diabetes.  For diabetes organisations, product suppliers and healthcare professionals you may wish to provide a written submission rather than completing the survey.

Written submissions should be limited to matters relating to product categories currently subsidised under the NDSS and be a maximum of 6 pages.  Written submissions will be considered in conjunction with the survey results.

Note that individual submissions will not receive a response from the Department. 

Written submissions can be sent to the following address: and must be received by the time the survey closes on 2 July 2023.

What happens next

The Department will consider the feedback received through the online survey and written submissions when planning the tender process for NDSS products.


  • Anyone from any background


  • Health technology
  • Pharmaceutical benefits
  • Chronic disease